Open Access
RESIDENT’S CORNER
Percutaneous cryoablation of a renal cell carcinoma in a transplanted kidney
Tommaso Silvestri1, Fulvio Stacul2, Michele Bertolotto3,
Mary Artero4, Salvatore Siracusano1
1 Department of Urology, University of Trieste, Trieste, Italy
2 Department of Radiology, AOU - Trieste Hospital, Trieste, Italy
3 Department of Radiology, University of Trieste, Trieste, Italy
4 Division of Nephrology and Dialysis, AOU – Trieste Hospital, Trieste, Italy
Address correspondence to Professor Salvatore Siracusano, Department of Urology, University of Trieste, Cattinara Hospital – Via Strada di Fiume 447, 34100 Trieste – Italy
Canadian Journal of Urology 2014, 21(4), 7390-7392.
Abstract
In patients who underwent renal transplantation, urinary tract tumors have an incidence of approximately 1.5%-3.3%. We report a rare case of renal cell carcinoma occurring in a transplanted kidney 25 years after the transplant. The lesion was treated by CT-guided percutaneous cryoablation with the ablation of renal lesion. This approach offers more accuracy compared with ultrasonography (US), and it is faster compared to magnetic resonance (MR) guidance. In transplanted kidneys, CT-guided cryoablation seems to be safe.
Keywords
renal cell carcinoma, renal transplant, percutaneous cryoablation
Cite This Article
APA Style
Silvestri, T., Stacul, F., Bertolotto, M., Artero, M., Siracusano, S. (2014). Percutaneous cryoablation of a renal cell carcinoma in a transplanted kidney. Canadian Journal of Urology, 21(4), 7390–7392.
Vancouver Style
Silvestri T, Stacul F, Bertolotto M, Artero M, Siracusano S. Percutaneous cryoablation of a renal cell carcinoma in a transplanted kidney. Can J Urology. 2014;21(4):7390–7392.
IEEE Style
T. Silvestri, F. Stacul, M. Bertolotto, M. Artero, and S. Siracusano, “Percutaneous cryoablation of a renal cell carcinoma in a transplanted kidney,” Can. J. Urology, vol. 21, no. 4, pp. 7390–7392, 2014.
Copyright © 2014 The Canadian Journal of Urology.